Pharmaceuticals

Rising Adoption Of Personalized Medicine Driving The Market Growth Due To Enhanced Efficiency And Safety In Individualized Treatments Is Supporting Development Across The Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Perfusion Bioreactor With Artificial Intelligence (AI) Control Market From 2026 To 2030?

The perfusion bioreactor with artificial intelligence (AI) control market has experienced significant growth in recent years. This market is expected to expand from $1.88 billion in 2025 to $2.28 billion in 2026, showing a compound annual growth rate (CAGR) of 21.1%. The growth observed in the past can be attributed to a rise in biologics manufacturing demand, the expansion of monoclonal antibody production, increasing adoption of perfusion-based cell culture, improvements in sensor and automation technologies, and the growing use of single-use bioprocessing systems.

The market size for perfusion bioreactors with artificial intelligence (ai) control is anticipated to experience substantial growth in the coming years. It is projected to reach a valuation of $4.85 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 20.8%. This expansion during the forecast period is primarily driven by factors such as increasing investments in AI-enabled biomanufacturing, rising demand for cell and gene therapies, wider adoption of continuous manufacturing, a heightened focus on process scalability and efficiency, and greater regulatory acceptance of advanced bioprocess technologies. Prominent trends expected in this period include the increasing adoption of AI-driven perfusion control systems, a growing reliance on continuous cell culture platforms, rising demand for single-use perfusion bioreactors, an expansion of real-time process optimization capabilities, and an enhanced emphasis on yield and process consistency.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=29146&type=smp

What Influential Factors Are Boosting The Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Demand?

The expanding adoption of personalized medicine is anticipated to fuel the growth of the perfusion bioreactor with artificial intelligence (AI) control market moving forward. Personalized medicine is a medical strategy focused on tailoring treatments to an individual’s genetic, molecular, and clinical attributes for more precise and effective care. This rise in personalized medicine is attributed to breakthroughs in genomics, which facilitate treatments customized to a patient’s specific genetic profile, leading to enhanced effectiveness and safety. Perfusion bioreactors with AI control support personalized medicine by enabling the precise and continuous production of patient-specific cells, such as stem cells or engineered tissues, under stringently controlled conditions. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. The personalized treatments newly approved in 2023 further encompassed seven cancer drugs and three for other diseases and conditions. Hence, the increasing prevalence of personalized medicine is a key driver for the perfusion bioreactor with artificial intelligence (AI) control market.

How Is The Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Structured Across Different Market Segments?

The perfusion bioreactor with artificial intelligence (ai) control market covered in this report is segmented –

1) By Product Type: Single Use Perfusion Bioreactors, Multi-Use Perfusion Bioreactors

2) By Artificial Intelligence (AI) Control Type: Predictive Analytics, Process Optimization, Real-Time Monitoring, Automated Feedback Control, Other Artificial Intelligence (AI) Control Types

3) By Application: Cell Therapy, Monoclonal Antibody Production, Vaccine Manufacturing, Stem Cell Research, Other Applications

4) By End-User: Biopharmaceutical Companies, Academic And Research Institutes, Contract Manufacturing Organizations, Other End-Users

Subsegments:

1) By Single-Use Perfusion Bioreactors: Disposable Bag Bioreactors, Modular Single-Chamber Bioreactors, Pre-Sterilized Single-Vessel Bioreactors

2) By Multi-Use Perfusion Bioreactors: Stainless Steel Bioreactors, Glass Bioreactors, Multi-Vessel Continuous Culture Systems

What Trends Are Influencing The Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Outlook?

Leading entities operating in the perfusion bioreactor with artificial intelligence (AI) control market are concentrating on advancing sophisticated strategies, such as AI-enhanced real-time bioprocess monitoring, to optimize cell culture performance, increase product yield, and lower operational expenses in biopharmaceutical manufacturing. AI-enhanced real-time bioprocess monitoring describes the application of artificial intelligence algorithms to continuously analyze data from bioreactors, thereby enabling instantaneous insights, predictive adjustments, and the optimization of cell growth and product quality during biomanufacturing. For example, in February 2025, The Cultivated B GmbH, a biotechnology company based in Germany, unveiled AI-driven multi-channel biosensors designed to improve real-time monitoring of bioreactors in cell culture and fermentation processes. These biosensors offer continuous, high-resolution data analytics, allowing bioprocess engineers to track growth and metabolism with remarkable sensitivity, detecting molecules such as glucose, amino acids, and lactic acid at sub-picomolar levels. The integration of AI provides real-time insights and recommendations to refine media formulation, enhance measurement reliability, diminish contamination risk by eliminating manual sampling, and accelerate product development for uses in pharmaceuticals, biologics, food biotechnology, waste upcycling, and alternative protein production.

Who Are The Firms Contributing To The Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Ecosystem?

Major companies operating in the perfusion bioreactor with artificial intelligence (ai) control market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG., Danaher Corporation, Sartorius Aktiengesellschaft, Getinge AB., WuXi Biologics Inc., Eppendorf Aktiengesellschaft, ABEC Inc., Catalyx.ai, PBS Biotech Inc., Cytovance Biologics, Culture Biosciences Inc., Esco Lifesciences Group Ltd., Cell Culture Company GmbH, Synthecon Inc., OmniBRx Biotechnologies Inc., ProlifeCell Inc., Sciperio Ltd., The Cultivated B Ltd.

Access The Complete Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Report:

https://www.thebusinessresearchcompany.com/report/perfusion-bioreactor-with-artificial-intelligence-ai-control-global-market-report

Which Region Accounts For The Highest Share Of The Perfusion Bioreactor With Artificial Intelligence (AI) Control Market?

North America was the largest region in the perfusion bioreactor with artificial intelligence (AI) control market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the perfusion bioreactor with artificial intelligence (ai) control market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=29146&type=smp

Browse Through More Reports Similar to the Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market 2026, By The Business Research Company

Perfusion Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/perfusion-systems-global-market-report

Artificial Intelligence In Cardiology Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cardiology-global-market-report

Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info